Cross-Over Evaluation of Two Lubricating Eye Drops

This study has been completed.
Sponsor:
Information provided by:
Innovative Medical
ClinicalTrials.gov Identifier:
NCT00493662
First received: June 26, 2007
Last updated: January 11, 2008
Last verified: January 2008

June 26, 2007
January 11, 2008
Not Provided
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00493662 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Cross-Over Evaluation of Two Lubricating Eye Drops
Not Provided

To evaluate the efficacy of two lubricating eye drops for the treatment of dry eye signs and symptoms.

Not Provided
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind
Dry Eye
  • Drug: Polyethylene Glycol 400 0.4%
  • Drug: Propylene Glycol 0.3%
  • Drug: 0.15% sodium Hyaluronate
  • Drug: sodium chloride
  • Drug: sodium phosphate monobasic
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  1. Patients 18 yrs or older
  2. Males or females
  3. Any race or ethnic background
  4. Patients with present ocular surface discomfort and a SESoD score of at least 2

Exclusion Criteria:

  1. Corneal refractive surgery within 6 months of this study.
  2. Contact lens use on day of examination.
  3. Corneal ectasia.
  4. Current use of Restasis
Both
18 Years and older
Not Provided
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00493662
5310
Not Provided
Not Provided
Innovative Medical
Not Provided
Principal Investigator: Tom Kislan, OD Hazleton Eye Specialists
Innovative Medical
January 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP